Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Annovis Bio Inc. (ANVS)

October 16, 2024 6:56 AM EDT Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $30.00 price target on Annovis Bio Inc. (NYSE: ANVS).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login